- Home
- FBRX vs EFR Comparison
FBRX vs EFR Comparison
Compare FBRX & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | EFR |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.4M | 333.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | EFR |
|---|---|---|
| Price | $31.38 | $11.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 176.8K | 88.6K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.90 | $10.95 |
| 52 Week High | $35.46 | $13.29 |
Technical Indicators
Market Signals| Indicator | FBRX | EFR |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 59.18 |
| Support Level | $29.79 | $11.18 |
| Resistance Level | $33.58 | $11.30 |
| Average True Range (ATR) | 3.49 | 0.08 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 70.81 | 75.00 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.